Investors with a lot of money to spend have taken a bearish stance on Viking Therapeutics VKTX.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with VKTX, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 14 uncommon options trades for Viking Therapeutics.
This isn't normal.
The overall sentiment of these big-money traders is split between 42% bullish and 50%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $521,480, and 7 are calls, for a total amount of $238,153.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $40.0 and $100.0 for Viking Therapeutics, spanning the last three months.
Insights into Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Viking Therapeutics options trades today is 344.29 with a total volume of 1,535.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Viking Therapeutics's big money trades within a strike price range of $40.0 to $100.0 over the last 30 days.
Viking Therapeutics Option Activity Analysis: Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | PUT | SWEEP | BULLISH | 05/16/25 | $22.3 | $22.1 | $22.2 | $67.50 | $288.6K | 73 | 138 |
| VKTX | CALL | TRADE | BULLISH | 05/16/25 | $3.4 | $3.3 | $3.4 | $100.00 | $68.0K | 545 | 207 |
| VKTX | PUT | TRADE | BEARISH | 12/06/24 | $20.1 | $16.5 | $18.95 | $70.00 | $56.8K | 83 | 30 |
| VKTX | PUT | TRADE | NEUTRAL | 01/16/26 | $33.9 | $32.4 | $33.08 | $75.00 | $52.9K | 373 | 16 |
| VKTX | PUT | TRADE | BULLISH | 11/22/24 | $5.2 | $4.8 | $4.92 | $55.00 | $34.4K | 155 | 152 |
About Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
In light of the recent options history for Viking Therapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Viking Therapeutics's Current Market Status
- Currently trading with a volume of 2,854,236, the VKTX's price is down by -4.56%, now at $51.13.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 82 days.
Expert Opinions on Viking Therapeutics
2 market experts have recently issued ratings for this stock, with a consensus target price of $96.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Reflecting concerns, an analyst from HC Wainwright & Co. lowers its rating to Buy with a new price target of $90. * Consistent in their evaluation, an analyst from HC Wainwright & Co. keeps a Buy rating on Viking Therapeutics with a target price of $102.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Viking Therapeutics, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
